Valuation: Haleon plc

Capitalization 2.99TCr 4TCr 3.44TCr 3.14TCr 5.5TCr 3,85400Cr 5.59TCr 38TCr 15TCr 1,82300Cr 15TCr 15TCr 6,35600Cr P/E ratio 2026 *
17.5x
P/E ratio 2027 * 15.7x
Enterprise value 3.67TCr 4.92TCr 4.23TCr 3.87TCr 6.76TCr 4,74100Cr 6.88TCr 46TCr 18TCr 2,24300Cr 18TCr 18TCr 7,81800Cr EV / Sales 2026 *
3.23x
EV / Sales 2027 * 3.04x
Free-Float
99.42%
Yield 2026 *
2.36%
Yield 2027 * 2.62%
1 day+0.98%
1 week+1.34%
Current month-0.15%
1 month-4.63%
3 months-16.61%
6 months-7.09%
Current year-9.42%
1 week 329
Extreme 329
341.85
1 month 325
Extreme 325
361.3
Current year 325
Extreme 325
416.1
1 year 274.4
Extreme 274.4
419.5
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 22/07/2021
Director of Finance/CFO 57 01/11/2024
Chief Tech/Sci/R&D Officer 63 01/08/2025
Director TitleAgeSince
Director/Board Member 59 23/05/2022
Chairman 71 01/01/2026
Director/Board Member 59 18/07/2022
Change 5d. change 1-year change 3-years change Capi.($)
+1.19%+1.34%-16.34%-0.16% 4TCr
+1.85%+0.32%+31.50%+124.47% 88TCr
-0.02%+2.03%+50.06%+43.99% 55TCr
+0.78%+1.08%+13.14%+44.79% 37TCr
+1.46%+1.06%+24.30%+13.90% 33TCr
+1.01%+2.09%+29.24%+30.73% 28TCr
+0.69%+0.38%+33.05%+14.90% 28TCr
+0.32%+0.40%+46.09%-2.31% 28TCr
+0.10%-3.52%-34.80%-51.51% 20TCr
-0.33%-3.92%+17.13%+44.62% 18TCr
Average +0.64%+1.28%+19.34%+26.34% 33.89TCr
Weighted average by Cap. +0.83%+1.71%+27.79%+48.69%

Financials

2026 *2027 *
Net sales 1.14TCr 1.53TCr 1.31TCr 1.2TCr 2.1TCr 1,47000Cr 2.13TCr 14TCr 5.56TCr 70TCr 5.72TCr 5.6TCr 2,42300Cr 1.19TCr 1.59TCr 1.37TCr 1.25TCr 2.19TCr 1,53300Cr 2.22TCr 15TCr 5.8TCr 73TCr 5.97TCr 5.84TCr 2,52800Cr
Net income 173.28Cr 232.1Cr 199.42Cr 182.46Cr 319.06Cr 22TCr 324.49Cr 2.18TCr 846.38Cr 11TCr 871.06Cr 852.6Cr 37TCr 189.14Cr 253.35Cr 217.67Cr 199.16Cr 348.27Cr 24TCr 354.2Cr 2.38TCr 923.88Cr 12TCr 950.81Cr 930.67Cr 40TCr
Net Debt 687.27Cr 920.56Cr 790.94Cr 723.68Cr 1.27TCr 89TCr 1.29TCr 8.66TCr 3.36TCr 42TCr 3.45TCr 3.38TCr 1,46300Cr 627.84Cr 840.95Cr 722.55Cr 661.1Cr 1.16TCr 81TCr 1.18TCr 7.91TCr 3.07TCr 38TCr 3.16TCr 3.09TCr 1,33600Cr
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
19/26/19 339.80 p +0.80% 25,49,303
18/26/18 337.10 p +1.26% 1,42,34,910
15/26/15 332.90 p +1.15% 2,30,60,840
14/26/14 329.10 p -0.21% 1,20,06,420
13/26/13 329.80 p -1.55% 2,19,58,660
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.371GBP
Average target price
4.175GBP
Spread / Average Target
+23.84%

Quarterly revenue - Rate of surprise